Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-24 @ 1:13 PM
NCT ID:
NCT05136495
Eligibility Criteria:
Inclusion Criteria:
* ADCY5 mutation carriers
* Age \> 15 years old and 3 months
* Informed consent from the patient or/ and a legal representative when appropriate
* Affiliated with a social security system or beneficiary of such a regime or by waiver from CPP ( french ethic committee) for patients outside the European union ( EU)
* daily caffeine consumer
Exclusion Criteria:
* Hypersensitivity to caffeine or to xanthine derivatives
* Heart condition contraindicating coffee intake
* Liver failure
* Impaired comprehension interfering with an informed consent
* Positive pregnancy test for women of childbearing potential
* Patient treated by Enoxacin, Ciprofloxacin, Norfloxacin (Noroxin), Cimetidine, Phenytoin β-adrenergic drugs (β2 mimetics) at inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT05136495
Study Brief:
Protocol Section:
NCT05136495